144 related articles for article (PubMed ID: 15144039)
1. [Reactogenicity of the simultaneous administration of influenza and pneumococcal vaccines in adults over 55 years of age].
Ayala-Montiel O; Mascareñas de los Santos C; García-Hernández D; Rendón-Muñiz J; García-Olvera L
Rev Invest Clin; 2004; 56(1):27-31. PubMed ID: 15144039
[TBL] [Abstract][Full Text] [Related]
2. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
Honkanen PO; Keistinen T; Kivelä SL
Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized double-blind controlled trial.
Jansen AG; Sanders EA; Smulders S; Hoes AW; Hak E
Pediatr Allergy Immunol; 2008 Sep; 19(6):552-8. PubMed ID: 18221474
[TBL] [Abstract][Full Text] [Related]
5. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
7. Does pneumococcal vaccine reduce influenza morbidity in humans?
Blay A; Bessler H; Lahad A; Waitman DA; Djaldetti M
Vaccine; 2007 Jan; 25(6):1071-5. PubMed ID: 17052814
[TBL] [Abstract][Full Text] [Related]
8. [Pneumococcal vaccination in adults].
Jonkers RE; Boersma WG
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):437-41. PubMed ID: 12666513
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with inactivated, virosomal influenza vaccine.
de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
[TBL] [Abstract][Full Text] [Related]
10. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
[TBL] [Abstract][Full Text] [Related]
11. Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(41):987-92. PubMed ID: 14561957
[TBL] [Abstract][Full Text] [Related]
12. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine.
Socan M; Frelih T; Janet E; Petras T; Peternelj B
Vaccine; 2004 Aug; 22(23-24):3087-91. PubMed ID: 15297059
[TBL] [Abstract][Full Text] [Related]
13. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A
J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651
[TBL] [Abstract][Full Text] [Related]
15. [Influenza and pneumococcal vaccination in adults].
Weinke T; Güthoff W
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S82-5. PubMed ID: 19353477
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K
Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631
[TBL] [Abstract][Full Text] [Related]
18. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015
[TBL] [Abstract][Full Text] [Related]
19. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
Schembri S; Morant S; Winter JH; MacDonald TM
Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
[TBL] [Abstract][Full Text] [Related]
20. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
